73365345ad5cfd5f165571982487ceee846c9918 mspeir Sat Feb 22 10:08:31 2025 -0800 adding announcement and hiding track by default, refs #32269 diff --git src/hg/htdocs/goldenPath/newsarch.html src/hg/htdocs/goldenPath/newsarch.html index 0eb433811bf..40da810e818 100755 --- src/hg/htdocs/goldenPath/newsarch.html +++ src/hg/htdocs/goldenPath/newsarch.html @@ -51,30 +51,58 @@

You can sign-up to get these announcements via our Genome-announce email list. We send around one short announcement email every two weeks.

Smaller software changes are not announced here. A summary of the three-weekly release changes can be found here. For the full list of our daily code changes head to our GitHub page. Lastly, see our credits page for acknowledgments of the data we host.

+ +

Feb. 21, 2025    New AlphaMissense scores track for hg38 and hg19

+

+We are pleased to announce the addition of AlphaMissense tracks to the hg38 and +hg19 reference genomes. AlphaMissense scores predict the pathogenicity of +missense variants for all possible single amino acid substitutions in the human +proteome. +

+ +

+To access these tracks on the Genome Browser, please visit their description +pages below and change the tracks' visibility: +

+ +

+To learn more about the AlphaMissense dataset, please see the +publication by Cheng et al. Science. 2023. +

+

Feb. 14, 2025    CIViC track for hg19 and hg38 is now available

We are excited to announce the release of the CIViC track for hg19/GRCh37 and hg38/GRCh38. The Clinical Interpretation of Variants in Cancer (CIViC) is an online database of clinically relevant variant interpretations from expert- and crowd-sourced peer-reviewed literature, clinical trials, and some conference abstracts. The details page for a feature will list diseases and therapies that have been associated with a genomic variant. Visiting the CIViC page for a variant will allow browsing the Molecular Profiles associated with that variant, and in turn each Molecular Profile shows the Clinical Evidence and Assertions for various diseases and therapies.